Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...

"On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest ...

Capricor management will present updates on its lead program of deramiocel for the treatment of Duchenne muscular dystrophy (DMD) as well as provide other general scientific and corporate updates. For ...

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital therapeutics ...

Although Outlook Therapeutics believes that it has a reasonable basis for the forward-looking statements contained herein, they are based on current expectations about future events affecting ...

Unveiling the Future of Chronic Insomnia treatment – DelveInsight's latest report explores epidemiological insights and market opportunities spanning the 7MM. LAS VEGAS , NV, UNITED STATES, January 31 ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has entered into a ...

DALLAS, Feb. 6, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing ...

Hanaman agrees. “The future of US healthcare is the future of digital,” he said. “All types of digital medicine, including DTx as standalone solutions and in combination with traditional ...

Breast cancer (BC) is the most common malignancy among females worldwide. Breast cancer is a highly heterogeneous malignant tumor which is constitutive of ...